BC Extra | Jul 11, 2015
Company News

Management tracks

Diagnostic play NanoString Technologies Inc. (NASDAQ:NSTG) named Alessandra Cesano CMO. Cesano was CMO at Cleave Biosciences Inc. (Burlingame, Calif.). Ophthalmic company Aerie Pharmaceuticals Inc. (NASDAQ:AERI) said CMO Brian Levy has left the company. Immunotherapy company...
BC Week In Review | Sep 9, 2013
Company News

Spectrum Pharmaceuticals sales and marketing update

Spectrum launched Marqibo vincristine in the U.S. to treat Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL) in patients with at least two relapses or in patients whose cancer has progressed following at least two leukemia therapies....
BC Week In Review | Jul 22, 2013
Company News

Spectrum Pharmaceuticals, Talon Therapeutics deal

Spectrum will acquire a 90% stake in Talon for $11.3 million, or $0.056 per share, in cash up front. The price is an 85% discount to the company's $0.37 close on July 16, before the...
BC Week In Review | May 20, 2013
Company News

Zosano management update

Zosano Pharma Inc. , Fremont, Calif.   Business: Drug delivery   Hired: Nandan Oza as COO, formerly VP of chemistry, manufacturing and controls at Talon Therapeutics Inc.  ...
BC Week In Review | Jan 14, 2013
Company News

Talon Therapeutics cancer news

Talon said its board authorized a review of strategic alternatives and that the company hired Goldman Sachs to provide financial advisory services. The review may lead to a possible transaction, including the merger or sale...
BioCentury | Jan 7, 2013
Finance

Buyside View XXI: Sunny side up

Stephen Hansen Senior Writer  A strong crop of early PDUFA dates and a sense that FDA is more navigable have given money managers in the U.S. and Europe a positive outlook for 2013, which they...
BioCentury | Oct 1, 2012
Finance

3Q Stock Wrap-Up: Back in black

Large cap biotechs stormed back after a weak 2Q12 to post a 7% gain for a third quarter in which every market cap segment finished in the black, albeit just barely for the micro-caps. For...
BioCentury | Aug 20, 2012
Product Development

Clawing towards approval

After 20 years in development at two companies, Marqibo vincristine sulfate received accelerated approval from FDA this month after Talon Therapeutics Inc. applied the lessons from a previous rejection by conducting a more thoroughly adjudicated...
BC Week In Review | Aug 13, 2012
Clinical News

Marqibo vincristine regulatory update

FDA granted accelerated approval to an NDA from Talon for Marqibo vincristine to treat Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL) in patients with >=2 relapses or in patients whose cancer has progressed following >=2 leukemia...
BioCentury | Aug 13, 2012
Finance

Highlights of weekly biotech stock moves

Regulatory milestones Alimera Sciences Inc. (NASDAQ:ALIM) fell $0.39 (14%) to $2.41 on Wednesday after the U.K.'s NICE issued draft guidance recommending against the use of Iluvien fluocinolone acetonide intravitreal implant to treat chronic diabetic macular...
Items per page:
1 - 10 of 139
BC Extra | Jul 11, 2015
Company News

Management tracks

Diagnostic play NanoString Technologies Inc. (NASDAQ:NSTG) named Alessandra Cesano CMO. Cesano was CMO at Cleave Biosciences Inc. (Burlingame, Calif.). Ophthalmic company Aerie Pharmaceuticals Inc. (NASDAQ:AERI) said CMO Brian Levy has left the company. Immunotherapy company...
BC Week In Review | Sep 9, 2013
Company News

Spectrum Pharmaceuticals sales and marketing update

Spectrum launched Marqibo vincristine in the U.S. to treat Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL) in patients with at least two relapses or in patients whose cancer has progressed following at least two leukemia therapies....
BC Week In Review | Jul 22, 2013
Company News

Spectrum Pharmaceuticals, Talon Therapeutics deal

Spectrum will acquire a 90% stake in Talon for $11.3 million, or $0.056 per share, in cash up front. The price is an 85% discount to the company's $0.37 close on July 16, before the...
BC Week In Review | May 20, 2013
Company News

Zosano management update

Zosano Pharma Inc. , Fremont, Calif.   Business: Drug delivery   Hired: Nandan Oza as COO, formerly VP of chemistry, manufacturing and controls at Talon Therapeutics Inc.  ...
BC Week In Review | Jan 14, 2013
Company News

Talon Therapeutics cancer news

Talon said its board authorized a review of strategic alternatives and that the company hired Goldman Sachs to provide financial advisory services. The review may lead to a possible transaction, including the merger or sale...
BioCentury | Jan 7, 2013
Finance

Buyside View XXI: Sunny side up

Stephen Hansen Senior Writer  A strong crop of early PDUFA dates and a sense that FDA is more navigable have given money managers in the U.S. and Europe a positive outlook for 2013, which they...
BioCentury | Oct 1, 2012
Finance

3Q Stock Wrap-Up: Back in black

Large cap biotechs stormed back after a weak 2Q12 to post a 7% gain for a third quarter in which every market cap segment finished in the black, albeit just barely for the micro-caps. For...
BioCentury | Aug 20, 2012
Product Development

Clawing towards approval

After 20 years in development at two companies, Marqibo vincristine sulfate received accelerated approval from FDA this month after Talon Therapeutics Inc. applied the lessons from a previous rejection by conducting a more thoroughly adjudicated...
BC Week In Review | Aug 13, 2012
Clinical News

Marqibo vincristine regulatory update

FDA granted accelerated approval to an NDA from Talon for Marqibo vincristine to treat Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL) in patients with >=2 relapses or in patients whose cancer has progressed following >=2 leukemia...
BioCentury | Aug 13, 2012
Finance

Highlights of weekly biotech stock moves

Regulatory milestones Alimera Sciences Inc. (NASDAQ:ALIM) fell $0.39 (14%) to $2.41 on Wednesday after the U.K.'s NICE issued draft guidance recommending against the use of Iluvien fluocinolone acetonide intravitreal implant to treat chronic diabetic macular...
Items per page:
1 - 10 of 139